SAHA treatment was able to significantly up-regulate the level of STAT3 starting from 0.5 μM concentration in H460 lung cancer cells, and the maximum elevation was seen with 7.5 and 10 μM concentrations (Figure 4A,B). The gene discussed is STAT3; the disease is lung carcinoma.